首页 | 本学科首页   官方微博 | 高级检索  
     

非洲爪蟾VEGF肿瘤疫苗治疗小鼠纤维肉瘤的研究
引用本文:牛挺,向兵,黄杰,文艳君,田聆,贾永前,刘霆,魏于全. 非洲爪蟾VEGF肿瘤疫苗治疗小鼠纤维肉瘤的研究[J]. 华西医学, 2005, 20(4): 696-697
作者姓名:牛挺  向兵  黄杰  文艳君  田聆  贾永前  刘霆  魏于全
作者单位:四川大学华西医院,生物治疗国家重点实验室,四川成都,610041;四川大学华西医院,血液科,四川成都,610041;四川大学华西医院,血液科,四川成都,610041;四川大学华西医院,生物治疗国家重点实验室,四川成都,610041;四川大学华西医院,肿瘤生物治疗科,四川成都,610041
基金项目:国家重点基础研究发展计划(973计划)项目(2004CB518807)和科技部基础研究重大项目前期研究专项(国科基字[2001]50号)资助.
摘    要:
目的:探讨非洲爪蟾VEGF肿瘤疫苗免疫抗小鼠纤维肉瘤的作用.方法:采用BALB/c小鼠建立Meth A小鼠纤维肉瘤模型.实验肿瘤小鼠随机分成3个治疗组:非洲爪蟾VEGF(xVEGF)组、小鼠VEGF(mVEGF)组、生理盐水对照(NS)组.观察小鼠肿瘤生长、生存率和治疗的毒副反应,并检测抗自身mVEGF抗体、肿瘤微血管密度(microvessel density, MVD).结果:xVEGF组肿瘤明显小于mVEGF组或NS对照组(P<0.05),xVEGF组小鼠生存率也明显高于mVEGF组或NS对照组(P<0.01).Western Blot检测发现异种蛋白质疫苗免疫的小鼠体内产生了抗自身mVEGF抗体,xVEGF组肿瘤MVD明显低于mVEGF组或NS对照组(P<0.01).结论:非洲爪蟾VEGF疫苗治疗可诱导纤维肉瘤小鼠产生抗自身VEGF免疫反应及抗肿瘤作用.

关 键 词:血管内皮细胞生长因子  异种肿瘤疫苗  免疫治疗
文章编号:1002-0179(2005)04-0696-02
收稿时间:2005-07-15
修稿时间:2005-07-15

Antitumor Effect of Xenopus Laevis VEGF Vaccine on Fibrosarcoma in Mice
NIU Ting, XIANG Bing, HUANG Jie,et al.. Antitumor Effect of Xenopus Laevis VEGF Vaccine on Fibrosarcoma in Mice[J]. West China Medical Journal, 2005, 20(4): 696-697
Authors:NIU Ting   XIANG Bing   HUANG Jie  et al.
Affiliation:1. State Key Laboratory of Biotherapy; 2. Department of Hematology; 3. Department of Biotherapy of Cancer, West China Hospital, Sichuan University, Chengdu 610041, China
Abstract:
Objective:To explore antitumor effect of immunotherapy with recombinant Xenopus laevis vascular endothelial growth factor(xVEGF)as a xenogeneic vaccine on fibrosarcoma in mice.Methods:Meth A fibrosarcoma model was established in BALB/c mice.These mice were randomly divided into three groups:xVEGF,mVEGF(mouse VEGF)and normal saline(NS)groups,and received relative treatments.Tumor growth,survival rate of tumor-bearing mice,and potential toxicity of the vaccines were investigated.Anti-mVEGF antibodies were detected by Western blot analysis.In addition,microvessel density(MVD)of tumor was detected by immunohistochemistry.Results:Tumor volumes of mice were significantly smaller in xVEGF group than in mVEGF or NS group(P<005),and survival rate of mice was also significantly higher in xVEGF group than in mVEGF or NS group(P<001).Anti-mVEGF antibodies were found by Western blot analysis in mice treated with xVEGF vaccine.Moreover, MVD in tumor tissues was significantly lower in xVEGF group than in mVEGF or NS group(P<001).Conclusion:Immunotherapy with xVEGF as a xenogeneic vaccine induces antitumor effect in mice by inducing immune response against self-VEGF.
Keywords:Vascular endothelial growth factor(VEGF)  Xenogeneic tumor vaccine  Immunotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号